MustGrow Biologics Corp.
MustGrow Biologics Corp.
Your view on MGRO.V
Overview
What the company does, where it operates, and who runs it.
About MustGrow Biologics Corp.
- Industry
- Agricultural Inputs
- Sector
- Basic Materials
- CEO
- Corey J. Giasson MBA
- Headquarters
- 201 1st Avenue South, Saskatoon, SK, CA
- Industry
- Agricultural Inputs
- Sector
- Basic Materials
- CEO
- Corey J. Giasson MBA
- Headquarters
- 201 1st Avenue South, Saskatoon, SK, CA
MustGrow Biologics Corp., an agricultural biotech company, focuses om development and commercialization of natural biopesticide, biofumigants, and bioherbicides derived from mustard seed. It provides preplant soil biofumigation, a technology to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and other crops.
The company is also developing bioherbicide to treat unwanted plant growth for use in organic agriculture, home, and garden markets, as well as agriculture markets; and postharvest food preservation, an application in sprout, disease, and pathogen treatment for storage and food preservation markets.
In addition, it focuses on providing CannaPM, an active ingredient to treat fungal soil diseases, as well as foliar diseases. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for MustGrow Biologics Corp., and the rating behind it. MGRO.V last traded at C$0.42; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for MustGrow Biologics Corp.. Starting points for MustGrow Biologics Corp.: EPS -C$0.09, beta 0.82 — an Agricultural Inputs name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for MustGrow Biologics Corp.. MustGrow Biologics Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for MustGrow Biologics Corp.. Trailing twelve-month EPS for MustGrow Biologics Corp. stands at -C$0.09. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for MustGrow Biologics Corp.. MustGrow Biologics Corp. has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
MustGrow Biologics Corp. valued side by side against its closest peers. MustGrow Biologics Corp. is measured against Agricultural Inputs peers within the Basic Materials sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold MustGrow Biologics Corp., and how their positions are changing. At a C$21.9M market value, institutional positions materially move MustGrow Biologics Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by MustGrow Biologics Corp. executives and directors. Shares of MustGrow Biologics Corp. have traded between C$0.42 and C$1.32 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming MustGrow Biologics Corp.. MustGrow Biologics Corp. is a C$21.9M Basic Materials company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming MustGrow Biologics Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for MustGrow Biologics Corp.. Coverage tracks MustGrow Biologics Corp. within Agricultural Inputs (Basic Materials). Press releases and market coverage, newest first.